Peptides, conjugates and method for increasing immunogenicity of a vaccine
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 20, 2016
Grant Date -
Mar 21, 2013
app pub date -
Mar 15, 2011
filing date -
Mar 15, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to conjugates comprising a peptide of at least 10 amino acid residues comprising the amino acid sequence GITELKKL (residues 383-390 of SEQ ID NO: 3) for induction of potent humoral and cellular immune responses when administered to subjects having antibodies against tetanus toxoid. In one embodiment the invention relates to a prophylactic and therapeutic vaccine and in a further embodiment the invention relates to the treatment or prevention of cancer or an infectious disease.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully